The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
The Biopharmaceutics Classification System: Subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC
Open accessAbstract
The Biopharmaceutics Classification System (BCS) has found widespread utility in drug discovery, product development and drug product regulatory sciences. The classification scheme captures the two most significant factors influencing oral drug absorption; solubility and intestinal permeability and it has proven to be a very useful and a widely accepted starting point for drug product development and drug product regulation. The mechanistic base of the BCS approach has, no doubt, contributed to its wide spread acceptance and utility. Nevertheless, underneath the simplicity of BCS are many detailed complexities, both in vitro and in vivo which must be evaluated and investigated for any given drug and drug product. In this manuscript we propose a simple extension of the BCS classes to include subspecification of acid (a), base (b) and neutral (c) for classes II and IV. Sub-classification for Classes I and III (high solubility drugs as currently defined) is generally not needed except perhaps in border line solubility cases. It is well known that the , pKa physical property of a drug (API) has a significant impact on the aqueous solubility dissolution of drug from the drug product both in vitro and in vivo for BCS Class II and IV acids and bases, and is the basis, we propose for a sub-classification extension of the original BCS classification. This BCS sub-classification is particularly important for in vivo predictive dissolution methodology development due to the complex and variable in vivo environment in the gastrointestinal tract, with its changing pH, buffer capacity, luminal volume, surfactant luminal conditions, permeability profile along the gastrointestinal tract and variable transit and fasted and fed states. We believe this sub-classification is a step toward developing a more science-based mechanistic in vivo predictive dissolution (IPD) methodology. Such a dissolution methodology can be used by development scientists to assess the likelihood of a formulation and dosage form functioning as desired in humans, can be optimized along with parallel human pharmacokinetic studies to set a dissolution methodology for Quality by Design (QbD) and in vitro–in vivo correlations (IVIVC) and ultimately can be used as a basis for a dissolution standard that will ensure continued in vivo product performance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Self-citationStrategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control
Yu, L. X. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9511-1 · Cited by 1,191
Transit of pharmaceutical dosage forms through the small intestine.
Davis, S. S., Hardy, J. G., & Fara, J. W. (1986) · Gut · doi:10.1136/gut.27.8.886 · Cited by 853
Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification
Kasim, N. A., Whitehouse, M., Ramachandran, C., Bermejo, M., Lennernäs, H., Hussain, A. S., Junginger, H. E., Stavchansky, S. A., Midha, K. K., Shah, V. P., et al. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034006h · Cited by 847
Self-citation(2001) · Drugs and the Pharmaceutical Sciences · doi:10.1201/9780824741969.axh · Cited by 818
Takagi, T., Ramachandran, C., Bermejo, M., Yamashita, S., Yu, L. X., & Amidon, G. L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0600182 · Cited by 606
Self-citationIntestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging
SCHILLER, C., FRÖHLICH, C. ‐., GIESSMANN, T., SIEGMUND, W., MÖNNIKES, H., HOSTEN, N., & WEITSCHIES, W. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02683.x · Cited by 596
In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs
Dressman, J. B., & Reppas, C. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00181-0 · Cited by 579
Physiological Parameters for Oral Delivery and in Vitro Testing
Mudie, D. M., Amidon, G. L., & Amidon, G. E. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100149j · Cited by 490
Self-citationClinical Pharmacokinetics of Ibuprofen: The First 30 Years
Davies, N. M. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834020-00002 · Cited by 440
Butler, J. M., & Dressman, J. B. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22217 · Cited by 427
Avdeef, A., Box, K. J., Comer, J. E. A., Hibbert, C., & Tam, K. Y. (1998) · Pharmaceutical Research · doi:10.1023/a:1011954332221 · Cited by 416
VERTZONI, M., DRESSMAN, J., BUTLER, J., HEMPENSTALL, J., & REPPAS, C. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.03.002 · Cited by 358
Dedicated Breast CT: Initial Clinical Experience
Lindfors, K. K., Boone, J. M., Nelson, T. R., Yang, K., Kwan, A. L. C., & Miller, D. F. (2008) · Radiology · doi:10.1148/radiol.2463070410 · Cited by 351
Budha, N. R., Frymoyer, A., Smelick, G. S., Jin, J. Y., Yago, M. R., Dresser, M. J., Holden, S. N., Benet, L. Z., & Ware, J. A. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.73 · Cited by 338
Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine
Kostewicz, E. S., Wunderlich, M., Brauns, U., Becker, R., Bock, T., & Dressman, J. B. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022511 · Cited by 318
Yazdanian, M., Briggs, K., Jankovsky, C., & Hawi, A. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016242.48642.71 · Cited by 290
Williams, H. D., Sassene, P., Kleberg, K., Bakala-N'Goma, J.-C., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., Jule, E., et al. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23205 · Cited by 274
Vertzoni, M., Fotaki, N., Nicolaides, E., Reppas, C., Kostewicz, E., Stippler, E., Leuner, C., & Dressman, J. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022935 · Cited by 236
Marciani, L., Cox, E. F., Hoad, C. L., Pritchard, S., Totman, J. J., Foley, S., Mistry, A., Evans, S., Gowland, P. A., & Spiller, R. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.055 · Cited by 218
Oral Drug Absorption: Prediction and Assessment
Dressman, J., & Lennernäs, H. (2000) · Medical Entomology and Zoology · Cited by 217
Oberle, R. L., & Amidon, G. L. (1987) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061761 · Cited by 208
Self-citationMiller, J. M., Beig, A., Krieg, B. J., Carr, R. A., Borchardt, T. B., Amidon, G. E., Amidon, G. L., & Dahan, A. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200181v · Cited by 204
Self-citationIbekwe, V. C., Fadda, H. M., McConnell, E. L., Khela, M. K., Evans, D. F., & Basit, A. W. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9580-9 · Cited by 199
Kostewicz, E. S., Brauns, U., Becker, R., & Dressman, J. B. (2002) · Pharmaceutical Research · doi:10.1023/a:1014407421366 · Cited by 180
Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum
Moreno, M. P. D. L. C., Oth, M., Deferme, S., Lammert, F., Tack, J., Dressman, J., & Augustijns, P. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.8.0009 · Cited by 180
Keating, G. M., & Croom, K. F. (2007) · Drugs · doi:10.2165/00003495-200767010-00013 · Cited by 169
Carvedilol dissolution improvement by preparation of solid dispersions with porous silica
Planinšek, O., Kovačič, B., & Vrečer, F. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.035 · Cited by 164
Anby, M. U., Williams, H. D., McIntosh, M. P., Benameur, H., Edwards, G. A., Pouton, C. W., & Porter, C. J. H. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300164u · Cited by 162
The influence of the interdigestive migrating myoelectric complex on the gastric emptying of liquids
Oberle, R. L., Chen, T.-S., Lloyd, C., Barnett, J. L., Owyang, C., Meyer, J., & Amidon, G. L. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91150-5 · Cited by 161
Self-citationTakano, R., Furumoto, K., Shiraki, K., Takata, N., Hayashi, Y., Aso, Y., & Yamashita, S. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9637-9 · Cited by 158
Ige, P. P., Baria, R. K., & Gattani, S. G. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.02.043 · Cited by 156
Prajapati, H. N., Dalrymple, D. M., & Serajuddin, A. T. M. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0541-3 · Cited by 150
Kataoka, M., Masaoka, Y., Yamazaki, Y., Sakane, T., Sezaki, H., & Yamashita, S. (2003) · Pharmaceutical Research · doi:10.1023/a:1026107906191 · Cited by 148
Williams, H. D., Anby, M. U., Sassene, P. J., Kleberg, K., N’Goma, J. B., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300331z · Cited by 142
Predicting Intestinal Precipitation—A Case Example for a Basic BCS Class II Drug
Carlert, S., Pålsson, A., Hanisch, G., von Corswant, C., Nilsson, C. A. M., Lindfors, L., Lennernäs, H., & Abrahamsson, B. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0213-8 · Cited by 141
Clinical Pharmacokinetics of Flurbiprofen and its Enantiomers
Davies, N. M. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199528020-00002 · Cited by 141
Clinical Relevance of Dissolution Testing in Quality by Design
Dickinson, P. A., Lee, W. W., Stott, P. W., Townsend, A. I., Smart, J. P., Ghahramani, P., Hammett, T., Billett, L., Behn, S., Gibb, R. C., et al. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9034-7 · Cited by 138
Gu, C., Rao, D. A., Gandhi, R. B., Hilden, J. O. N., & Raghavan, K. S. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20242 · Cited by 136
Carino, S. R., Sperry, D. C., & Hawley, M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20495 · Cited by 136
Yamashita, S., Tanaka, Y., Endoh, Y., Taki, Y., Sakane, T., NADAI, T., & Sezaki, H. (1997) · Pharmaceutical Research · doi:10.1023/a:1012103700981 · Cited by 133
Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers
Huang, Y. C., Colaizzi, J. L., Bierman, R. H., Woestenborghs, R., & Heykants, J. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.2.206 · Cited by 123
Dahan, A., & Amidon, G. L. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00102.2009 · Cited by 121
Self-citationFriedman, D. I., & Amidon, G. L. (1989) · Pharmaceutical Research · doi:10.1023/a:1015978420797 · Cited by 116
Self-citationVertzoni, M., Diakidou, A., Chatzilias, M., Söderlind, E., Abrahamsson, B., Dressman, J., & Reppas, C. I. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0223-6 · Cited by 116
Toward anIn VivoDissolution Methodology: A Comparison of Phosphate and Bicarbonate Buffers
Sheng, J. J., McNamara, D. P., & Amidon, G. L. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800148u · Cited by 111
Self-citationDrug Solubility in Luminal Fluids from Different Regions of the Small and Large Intestine of Humans
Fadda, H. M., Sousa, T., Carlsson, A. S., Abrahamsson, B., Williams, J. G., Kumar, D., & Basit, A. W. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100198q · Cited by 108
Kataoka, M., Masaoka, Y., Sakuma, S., & Yamashita, S. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20691 · Cited by 103
Kovačević, I., Parojčić, J., Homšek, I., Tubić-Grozdanis, M., & Langguth, P. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800128y · Cited by 99
Self-citationTubić-Grozdanis, M., Bolger, M. B., & Langguth, P. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9023-x · Cited by 99
Self-citationTsume, Y., & Amidon, G. L. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100053q · Cited by 96
Self-citationMudie, D. M., Shi, Y., Ping, H., Gao, P., Amidon, G. L., & Amidon, G. E. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1803 · Cited by 92
Self-citationThe BCS: Where Do We Go from Here?
Dressman, J., Butler, J., Hempenstall, J., & Reppas, C. I. (2001) · Pharmaceutical technology · Cited by 89
Kortejärvi, H., Urtti, A. O., & Yliperttula, M. L. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.10.011 · Cited by 87
Kataoka, M., Sugano, K., Mathews, C. D. C., Wong, J. W., Jones, K. L., Masaoka, Y., Sakuma, S., & Yamashita, S. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0623-2 · Cited by 84
Novel oral colon-specific drug delivery systems for pharmacotherapy of peptides and nonpeptide drugs
Reddy, S. (1999) · Drugs of today · doi:10.1358/dot.1999.35.7.548266 · Cited by 82
Biowaiver monographs for immediate release solid oral dosage forms: Rifampicin
Becker, C., Dressman, J., Junginger, H. E., Kopp, S., Midha, K. K., Shah, V. P., Stavchansky, S., & Barends, D. M. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21624 · Cited by 80
Willmann, S., Thelen, K., Becker, C., Dressman, J., & Lippert, J. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.003 · Cited by 78
Identification of Biowaivers Among Class II Drugs: Theoretical Justification and Practical Examples
Rinaki, E., Dokoumetzidis, A., Valsami, G. N., & Macheras, P. E. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000041450.25106.c8 · Cited by 76
In vitro–in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol
Jinno, J.-I., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Toguchi, H., Liversidge, G. G., Higaki, K., & Kimura, T. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.013 · Cited by 76
Holtmann, G., Kelly, D. G., Sternby, B., & DiMagno, E. P. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.2.g553 · Cited by 71
Baxter, J. G., Brass, C., Schentag, J. J., & Slaughter, R. L. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600750504 · Cited by 67
Fei, Y., Kostewicz, E. S., Sheu, M., & Dressman, J. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.03.001 · Cited by 66
Agrawal, S., & Panchagnula, R. (2005) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.464 · Cited by 65
Comparison and Analysis of Theoretical Models for Diffusion-Controlled Dissolution
Wang, Y., Abrahamsson, B., Lindfors, L., & Brasseur, J. G. (2012) · Molecular Pharmaceutics · doi:10.1021/mp2002818 · Cited by 65
Sugano, K. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1001119 · Cited by 64
Bhattachar, S., Perkins, E. J., Tan, J. S., & Burns, L. J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22669 · Cited by 62
Carino, S. R., Sperry, D. C., & Hawley, M. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22236 · Cited by 57
Ibuprofen disposition in obese individuals
Abernethy, D. R., & Greenblatt, D. J. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780281006 · Cited by 57
Sheng, J. J., Sirois, P. J., Dressman, J., & Amidon, G. L. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21345 · Cited by 53
Self-citationIn Vivo Dog Intestinal Precipitation of Mebendazole: A Basic BCS Class II Drug
Carlert, S., Åkesson, P., Jerndal, G., Lindfors, L., Lennernäs, H., & Abrahamsson, B. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300224h · Cited by 47
Amidon, K. S., Langguth, P., Lennernäs, H., Yu, L., & Amidon, G. L. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.109 · Cited by 44
Self-citationKataoka, M., Yano, K., Hamatsu, Y., Masaoka, Y., Sakuma, S., & Yamashita, S. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.06.018 · Cited by 42
Integrating drug permeability with dissolution profile to develop IVIVC
Takano, R., Kataoka, M., & Yamashita, S. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1792 · Cited by 41
Bhattachar, S., Risley, D. S., Werawatganone, P., & Aburub, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.018 · Cited by 32
Yun, H., Lee, E. J., Chung, S. Y., Choi, S.-O., Kim, H. K., Kwon, J., Kang, W., & Kwon, K. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645040-00007 · Cited by 30
EFFECT OF STRESS ON THE GASTRIC EMPTYING OF CAPSULES
Kaus, L. C., & Fell, J. T. (1984) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1984.tb01083.x · Cited by 15
Single oral dose pharmacokinetics and comparative bioavailability of danazol in humans
Hooper, W. D., Eadie, M. J., & DICKINSON, R. G. (1991) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510120804 · Cited by 13
Gastrointestinal scintiscanning: dosimetry
Madsen, J., & Krogsgaard, O. W. (1989) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00257544 · Cited by 8
Cited by
Mudie, D. M., Murray, K., Hoad, C. L., Pritchard, S. E., Garnett, M. C., Amidon, G. L., Gowland, P. A., Spiller, R. C., Amidon, G. E., & Marciani, L. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500210c · Cited by 486
Self-citationShah, V. P., & Amidon, G. L. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9620-9 · Cited by 150
Self-citation
Metadata
- Authors
- Tsume, Y., Mudie, D. M., Langguth, P., Amidon, G. E., & Amidon, G. L.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 57
- Pages
- 152-163
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2135130257
- Cited by
- 350
- References
- 81
- FWCI
- 9.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.